The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their crucial role in global healthcare. This move reinforces India’s position as a key provider of affordable generic medicines. Leaders highlight the strategic importance of the bilateral trade relationship, with the exemption offering India a chance to enhance its pharmaceutical sector.
Related Posts
Delhi’s 2nd-worst air day on record, SC says Grap-4 to go on till further orders
The Supreme Court directed Delhi and neighboring states to implement strict pollution control measures as air quality reached alarming levels. The court ordered schools to […]
PM Modi holds delegation-level talks with European Commission chief Ursula
Prime Minister Narendra Modi met European Commission President Ursula von der Leyen in Delhi to discuss enhancing their strategic partnership. Von der Leyen, leading the […]
Cab driver killed by minor, 4 others over fare dispute of Rs 400
A 26-year-old Delhi taxi driver was fatally stabbed after a fare dispute escalated. Five people, including a juvenile, allegedly attacked the driver after refusing to […]